Innovation1 Biotech Inc. (IVBT)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jul 7, 2025, 4:00 PM EDT
Innovation1 Biotech Company Description
Innovation1 Biotech Inc., researches, develops, produces, and sells pharmaceutical products in the United States.
It offers natural supplements for the treatment of flu and long covid under the NutraFlu and Nutravid19 brands; and NLC001 which is in Phase II clinical trial for the treatment of long covid and other viral indications.
The company is based in New York, New York.
Innovation1 Biotech Inc.
Country | United States |
Founded | 2014 |
Industry | Shell Companies |
Sector | Financials |
CEO | Francis Knuettel |
Contact Details
Address: 169 Madison Avenue New York, Nevada 10016 United States | |
Phone | (212) 292-3115 |
Stock Details
Ticker Symbol | IVBT |
Exchange | OTCMKTS |
Stock Type | Common Stock |
Fiscal Year | September - August |
Reporting Currency | USD |
ISIN Number | US39809D1028 |
SIC Code | 9995 |
Key Executives
Name | Position |
---|---|
Francis Knuettel II, M.B.A. | Executive Chairman and Interim Chief Executive Officer |
Samuel J. Knipper | Chief Financial Officer |
Tammy Phillips | Managing Director |